# The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

> **NCT07131826** · — · NOT_YET_RECRUITING · sponsor: **National Taiwan University Clinical Trial Center** · enrollment: 200 (estimated)

## Conditions studied

- Viral Control
- Quality of Life
- Cabotegravir
- Rilpivirine
- AIDS

## Interventions

- **OTHER:** Observational study, non-interventional

## Key facts

- **NCT ID:** NCT07131826
- **Lead sponsor:** National Taiwan University Clinical Trial Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07131826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07131826, "The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07131826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
